18631988|t|Prevention therapeutics of dementia.
18631988|a|In the absence of effective drugs for Alzheimer's disease (AD) and a validated roadmap or guideline for drug development, it is important to consider some of the limitations currently hampering AD drug development and some general principles for moving forward. This paper will address current barriers to developing drugs for AD, and offer new considerations for accelerating drug discovery, development, and clinical trials.
18631988	27	35	dementia	Disease	MESH:D003704
18631988	75	94	Alzheimer's disease	Disease	MESH:D000544
18631988	96	98	AD	Disease	MESH:D000544
18631988	231	233	AD	Disease	MESH:D000544
18631988	364	366	AD	Disease	MESH:D000544

